Dionymer Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$8.22M
- Investors
-
11
Dionymer General Information
Description
Developer of a biotechnology platform designed to transform biowaste into circular and biodegradable polymer materials that can replace conventional petrochemical plastics. The company's platform offers a proprietary bacterial fermentation process that produces PHA polymers suitable for cosmetic formulations, encapsulation applications, and bioplastics, enabling manufacturers across consumer, industrial, and packaging sectors to use biodegradable materials that align with natural cycles and reduce dependence on fossil-based inputs.
Contact Information
Website
www.dionymer.comCorporate Office
- 14 Avenue Pey Berland
- Building C - ENSMAC
- 33600 Pessac
- France
Corporate Office
- 14 Avenue Pey Berland
- Building C - ENSMAC
- 33600 Pessac
- France
Dionymer Timeline
Dionymer Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 02-Feb-2026 | $8.22M | Completed | Generating Revenue | ||
| 5. Grant | 09-Apr-2025 | Completed | Generating Revenue | |||
| 4. Seed Round | 12-Dec-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Dec-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 05-Oct-2021 | $23.5K | $23.5K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Dionymer Patents
Dionymer Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4658803-A1 | Method for obtaining a solution of volatile fatty acids, solution obtained, and use for the production of polyhydroxyalkanoates | Pending | 31-Jan-2023 | ||
| WO-2024160870-A1 | Method for obtaining a solution of volatile fatty acids, solution obtained, and use for the production of polyhydroxyalkanoates | Inactive | 31-Jan-2023 | ||
| FR-3145292-A1 | Process for obtaining a solution of volatile fatty acids, solution obtained and use for the production of polyhydroxyalkanoates | Pending | 31-Jan-2023 | C12P7/54 |
Dionymer Signals
Dionymer Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BNP Paribas Développement | PE/Buyout | Minority | ||
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| M Capital Partners | Growth/Expansion | Minority | ||
| UI Investissement | PE/Buyout | Minority | ||
| AFI Ventures (Paris) | Impact Investing | Minority |
Dionymer FAQs
-
When was Dionymer founded?
Dionymer was founded in 2021.
-
Where is Dionymer headquartered?
Dionymer is headquartered in Pessac, France.
-
What is the size of Dionymer?
Dionymer has 20 total employees.
-
What industry is Dionymer in?
Dionymer’s primary industry is Specialty Chemicals.
-
Is Dionymer a private or public company?
Dionymer is a Private company.
-
What is Dionymer’s current revenue?
The current revenue for Dionymer is .
-
How much funding has Dionymer raised over time?
Dionymer has raised $10.4M.
-
Who are Dionymer’s investors?
BNP Paribas Développement, Bpifrance, M Capital Partners, UI Investissement, and AFI Ventures (Paris) are 5 of 11 investors who have invested in Dionymer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process